Clinical and research tests for 896 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 3

Results: 21 to 40 of 44

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis PathGroup United States	23	160	T Targeted variant analysis
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant PathGroup United States	18	160	T Targeted variant analysis
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS PathGroup United States	17	160	T Targeted variant analysis
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 PathGroup United States	17	160	T Targeted variant analysis
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR PathGroup United States	16	160	T Targeted variant analysis
Tempus xF Tempus AI - CHI United States	1	105	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
NeoTYPE® Discovery Profile for Solid Tumors NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States	1	315	I Immunohistochemistry F Fluorescence in situ hybridization (FISH) C Sequence analysis of the entire coding region
ProvSeq 523 Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States	1	523	C Sequence analysis of the entire coding region
Comprehensive Hematologic Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	215	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Comprehensive Solid Tumor Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	315	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
OnkoSight Advanced Comprehensive Solid Tumor Panel (DNA/RNA) BioReference Health United States	1	523	C Sequence analysis of the entire coding region
OnkoSight Advanced 523 Gene NGS Panel BioReference Health United States	1	523	C Sequence analysis of the entire coding region
MI Tumor Seek Hybrid Caris Life Sciences United States	1	591	R RNA analysis C Sequence analysis of the entire coding region
OncoAlly™ Solid Tumor Analysis Variantyx, Inc. United States	1	433	D Deletion/duplication analysis X Mutation scanning of select exons R RNA analysis
Solid Tumor Expanded Panel Quest Diagnostics Nichols Institute San Juan Capistrano United States	1	523	I Microsatellite instability testing (MSI) R RNA analysis C Sequence analysis of the entire coding region
Paired Tumor/Normal - Hematologic Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	119	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Paired Tumor/Normal - Comprehensive Hematologic Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	215	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Translocation (6;14)(p21;q32)(CCND3/IGH) FISH Duzen Laboratories Duzen BBAGUAS Turkey	1	2	I FISH-interphase
Paired Tumor/Normal - Solid Tumor Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	239	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Paired Tumor/Normal - Comprehensive Solid Tumor Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	2	315	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region

<< First < Prev

Page 2 of 3

Results: 21 to 40 of 44

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.